Collegeville, PA, United States of America

Kang Yan

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Smithkline Beecham Corporation. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kang Yan. Retrieved from https://idiyas.com/inventor/kang-yan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Kang Yan

Introduction

Kang Yan is an accomplished inventor based in Collegeville, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of polynucleotides and polypeptides.

Latest Patents

Kang Yan holds a patent for "Polynucleotides encoding Staphylococcus aureus FtsA polypeptide." This invention provides FtsA polypeptide and polynucleotides encoding FtsA polypeptides, along with methods for producing such polypeptides through recombinant techniques. Additionally, the patent outlines methods for utilizing FtsA polypeptides to screen for antibacterial compounds. He has 1 patent to his name.

Career Highlights

Kang Yan is associated with SmithKline Beecham Corporation, where he has been instrumental in advancing research and development in his area of expertise. His work has contributed to the understanding and potential treatment of bacterial infections.

Collaborations

One of his notable collaborators is Kenneth H Pearce, Jr. Together, they have worked on various projects that aim to enhance the efficacy of antibacterial treatments.

Conclusion

Kang Yan's innovative work in biotechnology, particularly with his patent on FtsA polypeptides, showcases his commitment to advancing medical science. His contributions are vital in the ongoing fight against bacterial infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…